TuHURA Biosciences (HURA) Cash Flow: Operating & Free Cash Flow

TuHURA Biosciences Cash Flow Statement Analysis

Values in millions USD

Income Statement Balance Sheet Cash Flow Ratios

Scale:

Scroll to see more

Cash flow statement showing operating, investing, and financing activities for TuHURA Biosciences, Inc. (HURA) - Annual data in millions USD
Breakdown	FY 2025	FY 2025	FY 2024	FY 2024	FY 2023	FY 2023	FY 2022	FY 2022	FY 2021	FY 2021	FY 2020	FY 2019	FY 2018
Period ending	Mar 2026	Dec 2025	Mar 2025	Dec 2024	Dec 2023	Jun 2023	Dec 2022	Jun 2022	Dec 2021	Jun 2021	Jun 2020	Jun 2019	Jun 2018
Operating Activities
Net Income	-30.05	-30.05	-21.68	-21.68	-14.65	-29.32	-22.66	-9.37	-	-7.02	-38.30	-9.13	-11.14
Depreciation & Amortization	0.07	0.07	0.12	0.12	0.18	0.18	0.37	0.37	0.38	0.38	0.03	0.01	0.02
Stock Based Compensation	6.42	6.42	1.96	1.96	0.48	0.48	0.22	0.22	0.65	0.65	0.00	0.00	0.00
Change in Working Capital	-3.15	-3.15	3.29	3.29	0.49	0.49	1.56	1.56	-0.49	-0.06	-2.65	0.49	0.58
Change in Accounts Receivable	0.00	-	0.00	-	-	0.00	-	0.00	-	0.00	0.00	0.02	0.04
Change in Accounts Payable	0.00	-3.76	0.00	3.64	-0.44	0.00	1.01	0.00	-	0.00	-0.07	0.21	0.30
Change in Other Working Capital	-3.15	0.61	3.29	1.28	0.01	0.49	-1.06	1.56	0.63	-0.06	-2.58	0.26	0.24
Other Operating Activities	-0.92	-0.92	1.59	1.28	0.01	16.22	0.02	-0.29	0.63	-0.53	22.06	0.70	0.69
Net Cash from Operating Activities	-27.63	-27.63	-14.73	-14.73	-11.95	-11.95	-7.51	-7.51	-6.56	-6.56	-18.86	-7.93	-9.85
Investing Activities
Capital Expenditures	-0.08	-0.08	-0.06	-0.06	-0.08	-0.08	-0.04	-0.04	0.00	0.00	-0.01	0.00	9.85
Acquisitions	-1.26	-1.26	-5.99	-5.99	-1.22	-1.22	-	0.00	-	0.00	0.97	0.00	0.00
Net Cash from Investing Activities	-1.34	-1.34	-6.05	-6.05	-1.30	-1.30	-0.04	-0.04	0.00	0.00	0.96	0.00	-0.01
Financing Activities
Debt Repayment	0.62	-2.33	28.57	-	-	2.69	-0.35	-0.35	-	0.29	0.00	0.00	0.00
Common Stock Issued	21.92	21.92	5.00	5.00	1.90	0.00	21.64	0.00	5.60	5.60	26.08	6.63	9.26
Common Stock Repurchased	0.00	-	0.00	-	-0.02	-0.02	-	0.00	-	0.00	0.00	0.00	0.00
Dividends Paid	-0.01	-0.01	0.00	-	-	0.00	-	0.00	-	-0.01	-0.01	-0.01	-0.01
Other Financing Activities	-2.61	-2.61	-3.80	-5.84	-0.04	0.00	-	16.60	-	1.16	-0.03	-0.03	0.00
Net Cash from Financing Activities	19.93	19.93	29.77	29.77	2.66	2.66	16.25	16.25	7.04	7.04	26.04	6.60	9.25
Summary
Net Change in Cash	-9.04	-9.04	8.99	8.99	-10.59	-10.59	8.71	8.71	0.48	0.48	8.15	-1.33	-0.61
Cash at Beginning of Period	12.66	12.66	3.67	3.67	14.25	14.25	5.55	5.55	5.07	5.07	2.39	3.72	6.59
Cash at End of Period	3.62	3.62	12.66	12.66	3.67	3.67	14.25	14.25	5.55	5.55	10.54	2.39	5.97
Free Cash Flow	-27.71	-27.71	-14.79	-14.79	-12.03	-12.03	-7.54	-7.54	-6.57	-6.57	-18.87	-7.93	0.00

Source: Company financial statements from annual and quarterly filings. Data as of Jun 30, 2026. Data sources and methodology

Frequently Asked Questions About TuHURA Biosciences Cash Flow

What is TuHURA Biosciences's free cash flow?

TuHURA Biosciences had negative free cash flow of $27.71M in fiscal 2025 (fiscal year ended Mar 31, 2026), operating cash flow of −$27.63M minus $76.08K of capital expenditures.

How much does TuHURA Biosciences spend on capital expenditures?

TuHURA Biosciences spent $76.08K on capital expenditures in fiscal 2025, compared with $57.91K a year earlier.

Does TuHURA Biosciences pay dividends or buy back shares?

Yes. In fiscal 2025 TuHURA Biosciences returned $8.36K in dividends to shareholders, according to its cash flow statement.

What is free cash flow?

Free cash flow is operating cash flow minus capital expenditures. It is the cash a company has left for dividends, buybacks, debt repayment or acquisitions after funding its operations and investment. Full definition